510(k) K946146
K946146 is an FDA 510(k) premarket notification submitted by Clinical Controls, Inc. for the device "CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION". The FDA issued a decision of Substantially Equivalent on January 24, 1995. The device falls under product code JJT (Enzyme Controls (Assayed And Unassayed)), a Class I device regulated under 21 CFR 862.1660. Clinical Controls, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 24, 1995
- Date Received
- December 16, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Controls (Assayed And Unassayed)
- Device Class
- Class I
- Regulation Number
- 862.1660
- Review Panel
- CH
- Submission Type